Second-generation immunotherapeutics in multiple sclerosis: can we discard their precursors?

O Finding
, J Sellner

Department of Neurology, Neurological Intensive Care Medicine and Neurorehabilitation

Research output: Contribution to journal › Review article › peer-review

16 Citations (Web of Science)

Original language	English
Pages (from-to)	416-428
Journal	DRUG DISCOVERY TODAY
Volume	26
Issue number	2
DOIs	https://doi.org/10.1016/j.drudis.2020.11.022
Publication status	Published - 2021

Access to Document

10.1016/j.drudis.2020.11.022

Cite this

@article{2d8f1410e982420893e187efd6f7c86c,

title = "Second-generation immunotherapeutics in multiple sclerosis: can we discard their precursors?",

author = "O Finding and J Sellner",

note = "Sellner: Paracelsus Med Univ, Christian Doppler Med Ctr, Dept Neurol, Salzburg, Austria;",

year = "2021",

doi = "10.1016/j.drudis.2020.11.022",

language = "English",

volume = "26",

pages = "416--428",

journal = "DRUG DISCOVERY TODAY",

issn = "1359-6446",

publisher = "Elsevier ",

number = "2",

}

TY - JOUR

T1 - Second-generation immunotherapeutics in multiple sclerosis: can we discard their precursors?

AU - Finding, O

AU - Sellner, J

N1 - Sellner: Paracelsus Med Univ, Christian Doppler Med Ctr, Dept Neurol, Salzburg, Austria;

PY - 2021

Y1 - 2021

U2 - 10.1016/j.drudis.2020.11.022

DO - 10.1016/j.drudis.2020.11.022

M3 - Review article

C2 - 33248250

SN - 1359-6446

VL - 26

SP - 416

EP - 428

JO - DRUG DISCOVERY TODAY

JF - DRUG DISCOVERY TODAY

IS - 2

ER -